EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unlocking the puzzle: non-defining mutations in SARS-CoV-2 proteome may affect vaccine effectiveness

Eugenia Ulzurrun, Ana Grande-Pérez, Daniel Del Hoyo, Cesar Guevara, Carmen Gil, Carlos Oscar Sorzano, Nuria E Campillo

Frontiers in Public Health · 2024

DOI: 10.3389/fpubh.2024.1386596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Public Health, 2024. Verfasst von Eugenia Ulzurrun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biological Research Margarita Salas, Spanish National Research Council (CSIC), Madrid, Spain. Hauptthemen laut MEDLINE: SARS-CoV-2, Mutation, COVID-19, COVID-19 Vaccines. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

SARS-CoV-2 variants are defined by specific genome-wide mutations compared to the Wuhan genome. However, non-clade-defining mutations may also impact protein structure and function, potentially leading to reduced vaccine effectiveness. Our objective is to identify mutations across the entire viral genome rather than focus on individual mutations that may be associated with vaccine failure and to examine the physicochemical properties of the resulting amino acid changes. Materials and methods Whole-genome consensus sequences of SARS-CoV-2 from COVID-19 patients were retrieved from the GISAID database. Analysis focused on Dataset_1 (7,154 genomes from Italy) and Dataset_2 (8,819 sequences from Spain). Bioinformatic tools identified amino acid changes resulting from codon mutations with frequencies of 10% or higher, and sequences were organized into sets based on identical amino acid combinations.

Results

Non-defining mutations in SARS-CoV-2 genomes belonging to clades 21 L (Omicron), 22B/22E (Omicron), 22F/23A (Omicron) and 21J (Delta) were associated with vaccine failure. Four sets of sequences from Dataset_1 were significantly linked to low vaccine coverage: one from clade 21L with mutations L3201F (ORF1a), A27- (S) and G30- (N); two sets shared by clades 22B and 22E with changes A27- (S), I68- (S), R346T (S) and G30- (N); and one set shared by clades 22F and 23A containing changes A27- (S), F486P (S) and G30- (N). Booster doses showed a slight improvement in protection against Omicron clades. Regarding 21J (Delta) two sets of sequences from Dataset_2 exhibited the combination of non-clade mutations P2046L (ORF1a), P2287S (ORF1a), L829I (ORF1b), T95I (S), Y145H (S), R158- (S) and Q9L (N), that was associated with vaccine failure.

Discussion

Vaccine coverage associations appear to be influenced by the mutations harbored by marketed vaccines. An analysis of the physicochemical properties of amino acid revealed that primarily hydrophobic and polar amino acid substitutions occurred. Our results suggest that non-defining mutations across the proteome of SARS-CoV-2 variants could affect the extent of protection of the COVID-19 vaccine. In addition, alteration of the physicochemical characteristics of viral amino acids could potentially disrupt protein structure or function or both.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2MutationCOVID-19COVID-19 VaccinesProteomeHumansGenome, ViralVaccine EfficacySpainItaly

Stichwörter der Autor:innen

SARS-CoV-2conservationmutationsproteomevaccine

Substanzen

COVID-19 VaccinesProteome

Autor:innen und Institutionen

  • Center for Biological Research Margarita Salas, Spanish National Research Council (CSIC), Madrid, Spain.
  • National Center for Biotechnology, Spanish National Research Council (CSIC), Madrid, Spain.
  • Institute of Mathematical Sciences, Spanish National Research Council (CSIC), Madrid, Spain.
  • Department of Cellular Biology, Genetics, and Physiology, University of Malaga, Málaga, Spain.
  • Mechatronics and Interactive Systems - MIST Research Center, Universidad Tecnológica Indoamérica, Quito, Ecuador.

Zitieren

APA

Ulzurrun, E., Grande-Pérez, A., Del Hoyo, D., Guevara, C., Gil, C., Sorzano, C. O., & Campillo, N. E. (2024). Unlocking the puzzle: non-defining mutations in SARS-CoV-2 proteome may affect vaccine effectiveness. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2024.1386596

Vancouver

Ulzurrun E, Grande-Pérez A, Del Hoyo D, Guevara C, Gil C, Sorzano CO, et al. Unlocking the puzzle: non-defining mutations in SARS-CoV-2 proteome may affect vaccine effectiveness. Frontiers in Public Health. 2024. doi:10.3389/fpubh.2024.1386596

BibTeX
@article{Ulzurrun2024,
  author = {Ulzurrun, Eugenia and Grande-Pérez, Ana and Del Hoyo, Daniel and Guevara, Cesar and Gil, Carmen and Sorzano, Carlos Oscar and Campillo, Nuria E},
  title = {Unlocking the puzzle: non-defining mutations in SARS-CoV-2 proteome may affect vaccine effectiveness},
  journal = {Frontiers in Public Health},
  year = {2024},
  doi = {10.3389/fpubh.2024.1386596}
}
Kostenlos starten →